151 related articles for article (PubMed ID: 10701306)
1. [Vasopeptidase inhibitors. Omapatrilat in hypertension and heart failure].
Heinzl S
Med Monatsschr Pharm; 2000 Feb; 23(2):38-41. PubMed ID: 10701306
[No Abstract] [Full Text] [Related]
2. Vasopeptidase inhibitors.
Weber MA
Lancet; 2001 Nov; 358(9292):1525-32. PubMed ID: 11705582
[TBL] [Abstract][Full Text] [Related]
3. Omapatrilat.
Drugs R D; 1999 Apr; 1(4):350-1. PubMed ID: 10566062
[No Abstract] [Full Text] [Related]
4. [Omapatrilat for treatment of heart failure].
Yamazaki T
Nihon Rinsho; 2007 May; 65 Suppl 5():173-5. PubMed ID: 17571381
[No Abstract] [Full Text] [Related]
5. [Omapatrilat--new drug for patients with hypertension and heart failure].
Dzielska-Olczak M
Pol Merkur Lekarski; 2005 Oct; 19(112):556-8. PubMed ID: 16379325
[TBL] [Abstract][Full Text] [Related]
6. Vasopeptidase inhibition: a new concept in blood pressure management.
Burnett JC
J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842
[TBL] [Abstract][Full Text] [Related]
7. Omapatrilat for the management of heart failure and hypertension.
Husereau DR
Issues Emerg Health Technol; 2001 Jun; (17):1-4. PubMed ID: 11776285
[TBL] [Abstract][Full Text] [Related]
8. Combined neutral endopeptidase inhibitors.
Cuculi F; Erne P
Expert Opin Investig Drugs; 2011 Apr; 20(4):457-63. PubMed ID: 21323474
[TBL] [Abstract][Full Text] [Related]
9. Omapatrilat.
Armstrong PW; Lorell BH; Nissen S; Borer J
Circulation; 2002 Aug; 106(6):e9011-2. PubMed ID: 12187916
[No Abstract] [Full Text] [Related]
10. Vasopeptidase inhibitors in heart failure.
Dawson A; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):156-9. PubMed ID: 12563565
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
Solomon SD; Skali H; Bourgoun M; Fang J; Ghali JK; Martelet M; Wojciechowski D; Ansmite B; Skards J; Laks T; Henry D; Packer M; Pfeffer MA;
Am Heart J; 2005 Aug; 150(2):257-62. PubMed ID: 16086927
[TBL] [Abstract][Full Text] [Related]
12. Vasopeptidase inhibitors--concepts and evidence.
Ruschitzka F; Corti R; Quaschning T; Hermann M; Lüscher TF
Nephrol Dial Transplant; 2001 Aug; 16(8):1532-5. PubMed ID: 11477147
[No Abstract] [Full Text] [Related]
13. MDL 100240.
Drugs R D; 1999 Apr; 1(4):348-9. PubMed ID: 10566061
[No Abstract] [Full Text] [Related]
14. Omapatrilat. Bristol-Myers Squibb.
Tabrizchi R
Curr Opin Investig Drugs; 2001 Oct; 2(10):1414-22. PubMed ID: 11890357
[TBL] [Abstract][Full Text] [Related]
15. Vasopeptidase inhibition in heart failure.
van Veldhuisen DJ; van Gilst WH
Lancet; 2000 Oct; 356(9240):1526. PubMed ID: 11081561
[No Abstract] [Full Text] [Related]
16. [Vasopeptidase inhibition: a new mechanism of action--a new antihypertensive drug].
Waeber B
Praxis (Bern 1994); 2000 Apr; 89(16):649-53. PubMed ID: 10823018
[TBL] [Abstract][Full Text] [Related]
17. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study.
Mitchell GF; Izzo JL; Lacourcière Y; Ouellet JP; Neutel J; Qian C; Kerwin LJ; Block AJ; Pfeffer MA
Circulation; 2002 Jun; 105(25):2955-61. PubMed ID: 12081987
[TBL] [Abstract][Full Text] [Related]
18. A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure.
Nathisuwan S; Talbert RL
Pharmacotherapy; 2002 Jan; 22(1):27-42. PubMed ID: 11794428
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and pharmacokinetics of omapatrilat in heart failure.
Kostis JB; Klapholz M; Delaney C; Vesterqvist O; Cohen M; Manning JA; Jemal M; Kollia GD; Liao WC
J Clin Pharmacol; 2001 Dec; 41(12):1280-90. PubMed ID: 11762555
[TBL] [Abstract][Full Text] [Related]
20. Recent clinical trials with omapatrilat: new developments.
Zanchi A; Maillard M; Burnier M
Curr Hypertens Rep; 2003 Aug; 5(4):346-52. PubMed ID: 12844471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]